Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01411397
Other study ID # strangulated hernia
Secondary ID
Status Completed
Phase N/A
First received August 4, 2011
Last updated August 5, 2011
Start date June 2005
Est. completion date January 2011

Study information

Verified date June 2005
Source Mansoura University
Contact n/a
Is FDA regulated No
Health authority Egypt: Ministry of Health and Population
Study type Interventional

Clinical Trial Summary

Primary suture repair increases the risk for recurrence, the fact of benefit of mesh repair in elective situations is documented, and many studies have reported beneficial outcomes of mesh hernioplasty in emergency situations. Still there is controversy of using such grafts in presence of intestinal resection.


Description:

Patients with acutely incarcerated hernias (with small intestine contents) who underwent polypropylene mesh hernioplasty were included in this prospective study from June 2005 through Jan. 2011, patients were categorized into 2 groups who required intestinal resection anastomosis (group I)or not (group II).


Recruitment information / eligibility

Status Completed
Enrollment 163
Est. completion date January 2011
Est. primary completion date January 2011
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria:

- strangulated hernias

Exclusion Criteria:

- above 75, under 18

- recurrent hernia

- peritonitis

- pure omentum contents ASA above 3

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Other:
SURGERY
REPAIR OF STRANGULATED HERNIA with intestinal resection
mesh repair
mesh repair of strangulated hernia without resection

Locations

Country Name City State
Egypt Mohamed Abdellatif Mansoura

Sponsors (1)

Lead Sponsor Collaborator
Mansoura University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary wound infection 5 weeks Yes
Secondary operative time the time from skin incision up to skin closure 3hours Yes
Secondary morbidity the perioperative complications 5 months Yes
Secondary recurrence of the hernia Recurrence of the hernia was defined as an apparent swelling or a palpable defect at the previous surgery site detected clinically or radiologically by ultrasound if needed 6months Yes